Active substanceCetirizineCetirizine
Similar drugsTo uncover
  • Alerza®
    pills inwards 
  • Zincet®
    pills inwards 
  • Zincet®
    syrup inwards 
  • Zirtek®
    pills inwards 
    FSB Farshim S.A.     Switzerland
  • Zirtek®
    drops inwards 
    FSB Farshim S.A.     Switzerland
  • Zodak®
    pills inwards 
    Zentiva c.s.     Czech Republic
  • Zodak®
    syrup inwards 
    Zentiva c.s.     Czech Republic
  • Zodak®
    drops inwards 
    Zentiva c.s.     Czech Republic
  • Letizen®
    pills inwards 
  • Letizen®
    solution inwards 
  • Parlazin®
    pills inwards 
  • Parlazin®
    drops inwards 
  • Cetirizine
    pills inwards 
    VERTEKS, AO     Russia
  • Cetirizine
    pills inwards 
    OZONE, LLC     Russia
  • Cetirizine
    pills inwards 
    REPLEK FARM Skopje, OOO     Macedonia
  • Cetirizine
    drops inwards 
    ATOLL, LLC     Russia
  • Cetirizine DS
    pills inwards 
  • Cetirizine Sandoz®
    pills inwards 
    Sandoz d.     Slovenia
  • Cetirizine Sandoz®
    drops inwards 
    Sandoz d.     Slovenia
  • Cetirizine-OBL
    pills inwards 
  • Cetirizine-Abrichin
    pills inwards 
  • Cetirizine-Abrichin
    pills inwards 
  • Cetirizine-Teva
    pills inwards 
  • Cetiriax
    pills inwards 
  • Cetrin®
    drops inwards 
  • Cetrin®
    syrup inwards 
  • Cetrin®
    pills inwards 
  • Dosage form: & nbsptfilm-covered laths
    Composition:

    Each film-coated tablet contains:

    Active substance: cetirizine dihydrochloride 10.00 mg;

    Excipients (core): corn starch 36.55 mg, lactose 65.00 mg, pregelatinized starch 1.15 mg, talc 1.15 mg, magnesium stearate 1.15 mg;

    Auxiliary substances (shell): hypromellose 1.40 mg, talc 0.50 mg, titanium dioxide 0.50 mg, macrogol 0.10 mg.

    Description:

    Tablets from white to creamy white, capsular-shaped, covered with a film sheath with a separation risk on one side and engraved "B" and "L", on the other side by an engraving "10".

    Pharmacotherapeutic group:H1-histamine receptor blocker
    ATX: & nbsp

    E.06.A.E.07   Cetirizine

    Pharmacodynamics:

    The active substance of the drug - cetirizine, belongs to the group of competitive antagonists of histamine, blocks H1-gistaminovye receptors. Cetirizine affects the histamine-dependent stage of allergic reactions, and also reduces the migration of eosinophils, limits the release of inflammatory mediators at the cellular stage of an allergic reaction. Prevents development and facilitates the course of allergic reactions, has an antiexudative, antipruritic effect, has almost no anticholinergic and antiserotonin effect. In therapeutic doses, it practically does not have a sedative effect.

    Pharmacokinetics:

    Quickly absorbed when taken orally. The maximum serum concentration is reached 1 hour after oral administration. In small amounts, it is metabolized in the liver. The half-life is 7-10 hours in adults, 6 hours in children 6-12 years.

    Indications:

    Seasonal and all-the-year-round allergic rhinitis and conjunctivitis, hay fever (hay fever), idiopathic urticaria and other allergic dermatoses, accompanied by itching and rashes.

    Contraindications:

    Hypersensitivity to the drug and other components of the drug, hydroxyzine.

    Children's age (up to 6 years).

    Pregnancy, lactation.

    Carefully:

    If the liver and / or kidney function is impaired, the elderly.

    Dosing and Administration:

    Inside adults and children over 12 years - 1 tablet (10 mg) once a day.

    Children from 6-12 years old - 1 tablet (10 mg) - once a day or 1/2 tablet (5 mg) 2 times a day.

    Patients with renal insufficiency moderate creatinine clearance (11-13 ml / min), patients on hemodialysis (creatinine clearance less than 7 ml / min), and patients with a violation of liver function, it is recommended to appoint 1/2 tablets per day.

    If you miss the time of taking the drug, the next dose should be taken as soon as possible. In the event that the time of the next administration of the drug is approaching, the next dose should be taken on schedule, without increasing the total dose.

    The drug Alersa® can be taken regardless of the meal.

    Tablets should be swallowed, not liquid, squeezed with a small amount of water.

    Side effects:

    In some cases, headache, drowsiness,dizziness, agitation, dry mouth, disorders of the gastrointestinal tract in the form of dyspepsia, abdominal pain, flatulence.

    Allergic reactions (angioedema, rash, hives, itching).

    Overdose:

    Symptoms: taking the drug once in a dose of more than 5 tablets may be accompanied by signs of intoxication in the form of drowsiness; in children, an overdose of the drug may be accompanied by anxiety and increased irritability, possibly the appearance of signs of anticholinergic action in the form of urine retention, dry mouth, constipation.

    Treatment: the drug should be discontinued, it is necessary to rinse the stomach, take Activated carbon, immediately consult a doctor.

    Interaction:

    It is not recommended without consulting a physician to combine the administration of Alerz® with other drugs.

    When taken concomitantly with bronchodilators containing as an active substance theophylline, it is possible to increase the frequency of side effects of cetirizine.

    Data on the interaction of cetirizine with alcohol have not been received to date, despite this, the use of alcoholic beverages in the treatment of cetirizine is not recommended.

    Special instructions: When eliminating unused packages of the drug, special precautions are not required.
    Effect on the ability to drive transp. cf. and fur:

    People taking the drug should be careful when working, requiring a high rate of mental and physical reactions (vehicle management, machine maintenance, work at height, etc.).

    Form release / dosage:

    Tablets, film-coated, 10 mg.

    Packaging:

    For 10 tablets in a contour squeeze box (blister) made of PVC / aluminum foil.

    Two blisters together with instructions for use are placed in a pack of cardboard.

    Storage conditions:

    Store in a dry, dark place at a temperature below 25 ° C.

    Keep out of the reach of children.
    Shelf life:

    3 years.

    Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N015774 / 01
    Date of registration:06.10.2009 / 13.08.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:Ipka Laboratories Ltd.Ipka Laboratories Ltd. India
    Manufacturer: & nbsp
    Representation: & nbspIPKA LABORATORIES LTD. IPKA LABORATORIES LTD. India
    Information update date: & nbsp06.07.2017
    Illustrated instructions
      Instructions
      Up